Paracel Explorer

Dernière publication·Juillet 2026

Cosentyx SensoReady

Secukinumabum — sol inj 150 mg/1ml

Novartis Pharma Schweiz AG

Swissmedic65226

Dossier20316

Remboursement

QP 10%

Modifications (16)